Prostate Cancer Moon Shot Update
MOON SHOTS PROGRAM
Help end prostate cancer
MD Anderson experts are conquering prostate cancer with new knowledge, new technology and new combinations of therapies designed to save lives.
ABOUT PROSTATE CANCER
The best new therapies
Researchers at MD Anderson are working hard to develop a deeper understanding of the biology of prostate cancer and a new array of therapies that can control the disease and preserve patients’ quality of life.
Prostate Cancer Moon Shot Leaders
Filippo G. Giancotti, M.D., Ph.D.
Professor, Cancer Biology
Christopher J. Logothetis, M.D.
Chair, Genitourinary Medical Oncology
Two drugs, one goal
Researchers at MD Anderson have launched a first-of-its-kind
clinical trial for a particular type of treatment-resistant prostate
cancer. They’re combining two drugs — abiraterone and enzalutamide —
to block the resistance pathways that arise in each drug alone. The
goal is to decrease the levels of testosterone that drive the
STORIES OF HOPE
Contain the problem
Air Force Veteran Donald Lowd took his fight against prostate cancer to MD Anderson.
Attacking the biology of prostate cancer
We’re capitalizing on recent clinical advances and new knowledge in prostate cancer progression. Research projects focus on using precisely targeted molecular therapies to exploit the unique characteristics of the tumor and the surrounding tissue that supports its growth.
STORIES OF HOPE
A remarkable life continued
“The doctors and staff at MD Anderson were my lifeboat,” says Jon Thompson. Successful treatment for prostate cancer enabled him to resume his life of adventure
Get comprehensive information about the facts, symptoms, diagnosis, and treatment of prostate cancer